Editor's Comment--How Dangerous is Testosterone Supplementation?
作者信息
Jenkins Lawrence C, Mulhall John P
机构信息
Urology Service Memorial Sloan-Kettering Cancer Center, USA.
出版信息
Int Braz J Urol. 2015 Mar-Apr;41(2):195-8. doi: 10.1590/S1677-5538.IBJU.2015.02.02.
Abstract
摘要
相似文献
1
Editor's Comment--How Dangerous is Testosterone Supplementation?
Int Braz J Urol. 2015 Mar-Apr;41(2):195-8. doi: 10.1590/S1677-5538.IBJU.2015.02.02.
2
Testosterone therapy: has overuse undermined use?
Lancet Diabetes Endocrinol. 2018 Mar;6(3):157. doi: 10.1016/S2213-8587(16)30062-6.
3
Controversy over Cardiovascular Risks of Testosterone Therapy.
Am J Nurs. 2015 May;115(5):17. doi: 10.1097/01.NAJ.0000465018.88189.53.
4
Testosterone use in women: how safe is it?
Curr Drug Saf. 2013 Apr;8(2):120-7. doi: 10.2174/1574886311308020005.
5
Testosterone therapy and prostate cancer--safety concerns are well founded.
Nat Rev Urol. 2015 Jan;12(1):48-54. doi: 10.1038/nrurol.2014.338.
6
Testosterone Therapy Did Not Increase Major Cardiovascular Events.
JAMA. 2023 Jul 18;330(3):211. doi: 10.1001/jama.2023.11959.
7
[Androgens and cardiovascular risk: A series of case report in the French and Canadian pharmacovigilance databases].
Prog Urol. 2018 May;28(6):315-321. doi: 10.1016/j.purol.2018.03.005. Epub 2018 Apr 9.
8
Testosterone supplementation and cardiovascular risk.
Trends Cardiovasc Med. 2015 Apr;25(3):258-60. doi: 10.1016/j.tcm.2014.11.002. Epub 2014 Nov 8.
9
Testosterone replacement in elderly men.
Geriatrics. 2007 Sep;62(9):15-8.
10
Feeling deflated? The low-T industry wants to pump you up. The promise. The science. The risk.
Time. 2014 Aug 18;184(6):36-43.
本文引用的文献
1
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis.
Expert Opin Drug Saf. 2014 Oct;13(10):1327-51. doi: 10.1517/14740338.2014.950653. Epub 2014 Aug 19.
2
Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.
JAMA. 2013 Nov 6;310(17):1829-36. doi: 10.1001/jama.2013.280386.
3
Sildenafil and cardioprotection.
Curr Pharm Des. 2013;19(39):6842-7. doi: 10.2174/138161281939131127110156.
4
Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis.
J Clin Endocrinol Metab. 2011 Oct;96(10):3007-19. doi: 10.1210/jc.2011-1137. Epub 2011 Aug 3.
5
Testosterone deficiency.
Am J Med. 2011 Jul;124(7):578-87. doi: 10.1016/j.amjmed.2010.12.027.
6
Adverse events associated with testosterone administration.
N Engl J Med. 2010 Jul 8;363(2):109-22. doi: 10.1056/NEJMoa1000485. Epub 2010 Jun 30.
7
Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis.
J Clin Endocrinol Metab. 2010 Jun;95(6):2560-75. doi: 10.1210/jc.2009-2575.
8
Low serum testosterone and mortality in male veterans.
Arch Intern Med. 2006;166(15):1660-5. doi: 10.1001/archinte.166.15.1660.
9
Prevalence of hypogonadism in males aged at least 45 years: the HIM study.
Int J Clin Pract. 2006 Jul;60(7):762-9. doi: 10.1111/j.1742-1241.2006.00992.x.
10
Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.
J Gerontol A Biol Sci Med Sci. 2005 Nov;60(11):1451-7. doi: 10.1093/gerona/60.11.1451.
Zotero 插件